Related Experiment Videos
Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates
L J Utrup1, J E Finlay, S F Rittenhouse
1Department of Microbial Cell Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Diagnostic Microbiology and Infectious Disease
|November 1, 1994
Abstract:
Susceptibilities of 414 nasal and 586 nonnasal Staphylococcus aureus isolates, both methicillin resistant and methicillin susceptible, to the topical antimicrobial agent mupirocin were compared. A susceptibility of 99.1% was observed for the 1000 isolates. Nasal and nonnasal isolates showed a similar 90% minimum inhibitory concentration (MIC90) and statistically equivalent percent susceptibilities.